Nuclear Imaging Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Diagnostic Imaging therapeutic area.
Nuclear medicine equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis.
Nuclear Imaging is a non-invasive medical technique that uses radioactive tracers, such as F-18 Fluorodeoxyglucose, to evaluate and diagnose various bodily functions and diseases, including cancers, cardiac, gastrointestinal, endocrine, and neurological conditions. Nuclear Imaging Equipment's have been classified into Positron Emission Tomography (PET) Systems and Single Photon Emission Computed Tomography (SPECT) Systems. The advanced version of these systems include PET/CT, PET/MRI, SPECT/CT and SPECT/MRI, incorporating features from both PET and CT/MRI or SPECT and CT/MRI.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Companies covered: GE HealthCare Technologies Inc, Siemens Healthineers AG, Philips Healthcare Informatics Inc, Canon Medical Systems Corp, Neusoft Medical Systems Co Ltd and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Nuclear medicine equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis.
Nuclear Imaging is a non-invasive medical technique that uses radioactive tracers, such as F-18 Fluorodeoxyglucose, to evaluate and diagnose various bodily functions and diseases, including cancers, cardiac, gastrointestinal, endocrine, and neurological conditions. Nuclear Imaging Equipment's have been classified into Positron Emission Tomography (PET) Systems and Single Photon Emission Computed Tomography (SPECT) Systems. The advanced version of these systems include PET/CT, PET/MRI, SPECT/CT and SPECT/MRI, incorporating features from both PET and CT/MRI or SPECT and CT/MRI.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are :
Currently marketed Nuclear Imaging Equipment and evolving competitive landscape :
- Insightful review of the key industry trends.
- Annualized total Nuclear Imaging Equipment market revenue by segment and market outlooks from 2015-2033.
- Market level data on units, average selling prices and market values.
Global, Regional and Country level market specific insights :
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition the analyst analysts provide unique country specific insights on the market.
- SWOT analysis for Nuclear Imaging Equipment market.
- Competitive dynamics insights and trends provided for Nuclear Imaging Equipment market.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Companies covered: GE HealthCare Technologies Inc, Siemens Healthineers AG, Philips Healthcare Informatics Inc, Canon Medical Systems Corp, Neusoft Medical Systems Co Ltd and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for :- CMO executives who must have deep understanding of the Nuclear Imaging Equipment marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to :
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
- Develop business strategies by understanding the trends shaping and driving Nuclear Imaging Equipment market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Nuclear Imaging Equipment market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Nuclear Imaging Equipment market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- GE HealthCare Technologies Inc
- Siemens Healthineers AG
- Philips Healthcare Informatics Inc
- Canon Medical Systems Corp
- Neusoft Medical Systems Co Ltd